On this 15th episode of the AMR Action Podcast, Christopher Micetich, President and CEO of both Brass Dome Ventures Ltd. and Fedora Pharmaceuticals Inc., joins Dani Peters, CAIC Senior Advisor, to discuss the current state of antimicrobial innovation within the biotech industry and the challenges faced in developing new solutions. He shares some of the history of antimicrobial innovation in Alberta, including the discovery of Tazobactam by his late father and team of researchers, and suggests how Alberta can position itself as a leader in antimicrobial innovation on a global scale, leveraging the upcoming G7 summit hosted in the region.

In honour of World Antimicrobial Resistance (AMR) Awareness Week (WAAW) 2024, the AMR Action Podcast welcomed guest speaker Damiano de Felice, Chief of External Affairs at CARB-X. This year’s WAAW theme is “Educate. Advocate. Act now.” In alignment with this theme, Damiano spoke about his work to advance conversations with governments around policies and actions needed to address AMR. Damiano shares his insights from Italy’s recent investments in AMR and his ideas on how Canada can prepare for its upcoming G7 presidency to enhance countries’ commitments to AMR.